Patents by Inventor Preston A. Marx

Preston A. Marx has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies directed against a novel pathogenic west African human immunodeficiency virus type 2 (HIV-2) group F isolate
    Patent number: 9650435
    Abstract: Isolated monoclonal antibodies that bind to HIV-2 isolate NWK08F are provided. In some embodiments, the antibodies bind a polypeptide comprising the HIV-2NWK08F Env, Pol, or Nef proteins, or fragments thereof, respectively. Antigen-binding fragments and humanized versions of the antibody are also provided.
    Type: Grant
    Filed: April 28, 2014
    Date of Patent: May 16, 2017
    Assignee: The Administrators of the Tulane Educational Fund
    Inventors: Stephen M. Smith, Preston A. Marx, Jr.
  • NOVEL HIV-2 ISOLATE
    Publication number: 20140234332
    Abstract: The invention provides a novel strain of HIV-2 capable of causing immunodeficiency. The invention also provides compositions comprising the nucleic acids and polypeptides characteristic of this HIV-2 virus, antibodies specific for this HIV-2 virus, methods of using these compositions, and methods of detecting HIV-2 virus.
    Type: Application
    Filed: April 28, 2014
    Publication date: August 21, 2014
    Applicant: Tulane University Health and Sciences Center
    Inventors: Stephen M. Smith, Preston A. Marx, JR.
  • Pathogenic west african human immunodeficiency virus type 2 (HIV-2) group F isolate
    Patent number: 8747862
    Abstract: The claimed invention is directed toward an HIV-2 isolate designated NWK08F, including variants, and isolated proteins and nucleotides obtained from said isolates.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: June 10, 2014
    Assignee: Tulane University Health Sciences Center
    Inventors: Stephen M. Smith, Preston A. Marx
  • NOVEL HIV-2 ISOLATE
    Publication number: 20120107909
    Abstract: The invention provides a novel strain of HIV-2 capable of causing immunodeficiency. The invention also provides compositions comprising the nucleic acids and polypeptides characteristic of this HIV-2 virus, antibodies specific for this HIV-2 virus, methods of using these compositions, and methods of detecting HIV-2 virus.
    Type: Application
    Filed: November 13, 2009
    Publication date: May 3, 2012
    Inventors: Stephen M. Smith, Preston A. Marx
  • Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey
    Publication number: 20030162170
    Abstract: The nucleotide sequence and deduced amino acid sequences of the complete genome of a simian immunodeficiency virus isolate from a red-capped mangabey are disclosed. The invention relates to the nucleic acids and peptides encoded by and/or derived from these sequences and their use in diagnostic methods and as immunogens.
    Type: Application
    Filed: February 18, 2003
    Publication date: August 28, 2003
    Applicant: UAB Research Foundation
    Inventors: Beatrice H. Hahn, Feng Gao, George M. Shaw, Preston A. Marx, Stephen M. Smith, Marie Claude Georges-Courbot, Chang Yong Lu
  • Complete genome sequence of a simian immunodeficiency virus from a red-capped mangabey
    Patent number: 6521739
    Abstract: The nucleotide sequence and deduced amino acid sequences of the complete genome of a simian immunodeficiency virus isolate from a red-capped mangabey are disclosed. The invention relates to the nucleic acids and peptides encoded by and/or derived from these sequences and their use in diagnostic methods and as immunogens.
    Type: Grant
    Filed: December 7, 1998
    Date of Patent: February 18, 2003
    Assignee: UAB Research Foundation
    Inventors: Beatrice H. Hahn, Feng Gao, George M. Shaw, Preston A. Marx, Stephen M. Smith, Marie Claude Georges-Courbot, Chang Yong Lu